Waleed Alhabeeb1, Abdelfatah Elasfar2, Hanan AlBackr3, Fayez AlShaer3, Ali Almasood4, Hussam Alfaleh3, Tarek Kashour3, Ahmad Hersi3, Kazi Nur Asfina3, Hani Altaradi3, Waleed AlShaqhaa5, Fakhr Alayoubi3, Khalid F AlHabib3. 1. King Fahad cardiac Center, College of Medicine, Department of Cardiac Sciences, King Saud University, Saudi Arabia. Electronic address: walhabeeb@ksu.edu.sa. 2. King Salman Heart Center, King Fahad Medical City, Riyadh, Saudi Arabia; Cardiology Department, Tanta University, Egypt. 3. King Fahad cardiac Center, College of Medicine, Department of Cardiac Sciences, King Saud University, Saudi Arabia. 4. Prince Sultan Cardiac Center, Riyadh, Saudi Arabia. 5. King Salman Heart Center, King Fahad Medical City, Riyadh, Saudi Arabia; Faculty of Medicine, Al-Imam Muhammad Ibn Saud Islamic University, Riyadh, Saudi Arabia.
Abstract
BACKGROUND: Several registries have described patients hospitalized with heart failure (HF), but only few looked at outpatients in the ambulatory setting mostly without long-term follow-up. We sought to determine the clinical characteristics, management, and 1-year outcomes of patients with chronic HF in Saudi Arabia. METHODS: Part of a prospective multicenter nationwide registry; HEart function Assessment Registry Trial in Saudi Arabia (HEARTS) and included chronic HF patients referred to four HFCs between September 2009 and December 2011. RESULTS: We enrolled 685 patients with mean age 55.66±15.97years, 70.1% were men and 96.1% were Saudis. The main etiologies of HF were CAD (38.8%), dilated cardiomyopathy (36.5%), and hypertension (10.5%). Severe left ventricular dysfunction was present in 70.6% and median NT-proBNP was 2934.37pg/ml. The prescription rates of evidence based therapies (EBTs) before admission to HFC, at discharge from 1st clinic visit, and at 1-year follow up were 90%, 91% and 94% for beta-blockers, 79%, 80%, and 86% for ACEi/ARBs and 44%, 45%, and 42% for aldosterone antagonists; respectively. ICD was inserted in 21.9% and CRT in 6.6% at enrollment and increased to 29.1% and 8.8% after one year respectively. The all-cause mortality rate at 1year was 9% and 93.7% of which was cardiac-related. The all-cause one-year hospitalization rate was 39% and the total emergency room visit rate was 50%. CONCLUSIONS: Chronic HF patients in Saudi Arabia are younger, commonly have severe LV systolic dysfunction and have relatively high annual mortality and re-hospitalization rates.
BACKGROUND: Several registries have described patients hospitalized with heart failure (HF), but only few looked at outpatients in the ambulatory setting mostly without long-term follow-up. We sought to determine the clinical characteristics, management, and 1-year outcomes of patients with chronic HF in Saudi Arabia. METHODS: Part of a prospective multicenter nationwide registry; HEart function Assessment Registry Trial in Saudi Arabia (HEARTS) and included chronic HFpatients referred to four HFCs between September 2009 and December 2011. RESULTS: We enrolled 685 patients with mean age 55.66±15.97years, 70.1% were men and 96.1% were Saudis. The main etiologies of HF were CAD (38.8%), dilated cardiomyopathy (36.5%), and hypertension (10.5%). Severe left ventricular dysfunction was present in 70.6% and median NT-proBNP was 2934.37pg/ml. The prescription rates of evidence based therapies (EBTs) before admission to HFC, at discharge from 1st clinic visit, and at 1-year follow up were 90%, 91% and 94% for beta-blockers, 79%, 80%, and 86% for ACEi/ARBs and 44%, 45%, and 42% for aldosterone antagonists; respectively. ICD was inserted in 21.9% and CRT in 6.6% at enrollment and increased to 29.1% and 8.8% after one year respectively. The all-cause mortality rate at 1year was 9% and 93.7% of which was cardiac-related. The all-cause one-year hospitalization rate was 39% and the total emergency room visit rate was 50%. CONCLUSIONS:Chronic HFpatients in Saudi Arabia are younger, commonly have severe LV systolic dysfunction and have relatively high annual mortality and re-hospitalization rates.
Authors: Ahmed Bennis; Elijah N Ogola; Eric Klug; Hadi N Skouri; Hilal Bahjet Al Saffar; Hany Ragy; Kamal Waheeb AlGhalayini; Khaldoon A Alhumood; Magdy Abdelhamid; Mehmet Birhan Yilmaz; Ramzi Tabbalat; Yüksel Çavuşoğlu Journal: J Saudi Heart Assoc Date: 2022-04-15